Jagsonpal Pharmaceuticals Limited

JAGSNPHARM

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 202681

    Quarter₹ croreYoY
    Sept 202475+29.2%
    Dec 202474+56.7%
    Mar 202559+34.7%
    Jun 202576+23.1%
    Sept 202574-0.3%
    Dec 202573-1.5%
    Mar 202664+9.6%
    Jun 202682+8.8%
    Sept 202681+9.3%
  • ₹ crore

    Sept 20262

    Quarter₹ crore
    Sept 20242
    Dec 20242
    Mar 20253
    Jun 20253
    Sept 20253
    Dec 20253
    Mar 20263
    Jun 20263
    Sept 20262
  • ₹ crore

    Sept 202684

    Quarter₹ crore
    Sept 202476
    Dec 202476
    Mar 202561
    Jun 202578
    Sept 202577
    Dec 202576
    Mar 202667
    Jun 202685
    Sept 202684
  • Cost structure
  • ₹ crore

    Sept 202622

    Quarter₹ crore
    Sept 202417
    Dec 202418
    Mar 202517
    Jun 202519
    Sept 202518
    Dec 202518
    Mar 202616
    Jun 202623
    Sept 202622
  • ₹ crore

    Sept 202667

    Quarter₹ crore
    Sept 202461
    Dec 202461
    Mar 202552
    Jun 202564
    Sept 202561
    Dec 202559
    Mar 202656
    Jun 202667
    Sept 202667
  • Exceptional items and tax
  • ₹ crore

    Sept 202617

    Quarter₹ crore
    Sept 202415
    Dec 202439
    Mar 20259
    Jun 202514
    Sept 202517
    Dec 202515
    Mar 202612
    Jun 202618
    Sept 202617
  • ₹ crore

    Sept 20264

    Quarter₹ crore
    Sept 20244
    Dec 20247
    Mar 20252
    Jun 20254
    Sept 20254
    Dec 20254
    Mar 20263
    Jun 20264
    Sept 20264
  • Profit
  • ₹ crore

    Sept 202613

    Quarter₹ croreYoY
    Sept 202411+53.4%
    Dec 202432+707.2%
    Mar 20257+85.5%
    Jun 202511+102.6%
    Sept 202513+9.7%
    Dec 202511-65.8%
    Mar 20269+33.1%
    Jun 202613+22.2%
    Sept 202613+0.1%
  • Per share
  • ₹ per share

    Sept 20261.91

    Quarter₹ per share
    Sept 20244.29
    Dec 20244.74
    Mar 20250.98
    Jun 20251.60
    Sept 20251.88
    Dec 20251.67
    Mar 20261.25
    Jun 20262.00
    Sept 20261.91
  • Leverage
  • Debt to equity

    times

    Jun 20250.00x

    Quartertimes
    Sept 2024—
    Dec 20240.00x
    Mar 20250.00x
    Jun 20250.00x
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
    Sept 2026—
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
757459767473648281
Revenue YoY+29.2%+56.7%+34.7%+23.1%-0.3%-1.5%+9.6%+8.8%+9.3%
223333332
767661787776678584
Cost structure
171817191818162322
616152646159566767
Exceptional items and tax
15399141715121817
472444344
Profit
1132711131191313
Net profit YoY+53.4%+707.2%+85.5%+102.6%+9.7%-65.8%+33.1%+22.2%+0.1%
Per share
4.294.740.981.601.881.671.252.001.91
Leverage
Debt to equity—0.00x0.00x0.00x—————

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.